Cordlife and Artivision unveil placement plans
The former expects to raise $32.1m from private placement and the latter $4.27m
Add BT as a preferred source
CORDLIFE Group and Artivision Technologies yesterday announced that they are raising funds via share placements.
Cordlife has proposed a private placement of 26.8 million shares that is expected to raise gross proceeds of $33.5 million. After deducting fees and expenses, the group expects to raise net proceeds of $32.1 million.
Cordlife, which runs a cord blood bank, intends to offer 17.8 million shares at $1.25 each via placement agent United Overseas Bank, while the remaining 9.038 million shares will be taken up by Caerus Capital and four other investors via subscription agreements.
TRENDING NOW
Singapore staff first to go in Meta’s 8,000 global job cuts
Xi Jinping has just rewritten the rules of US-China rivalry
‘Even a CEO’s job can be replaced by AI’: DBS CEO Tan Su Shan bets big on agentic AI
OpenAI picks Singapore for first Applied AI Lab outside US in S$300 million push to tap ‘incredible talent here’
